SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
60 hedge funds and large institutions have $15.3M invested in Seelos Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
Holders
60
Holding in Top 10
–
Calls
$381K
Puts
$91K
Top Buyers
| 1 | +$661K | |
| 2 | +$146K | |
| 3 | +$111K | |
| 4 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$47.2K |
| 5 |
TCOT
Trust Company of Toledo
Holland,
Ohio
|
+$38K |
Top Sellers
| 1 | -$668K | |
| 2 | -$577K | |
| 3 | -$470K | |
| 4 |
BlackRock
New York
|
-$84.9K |
| 5 |
Millennium Management
New York
|
-$84.8K |